Jeff Liter

Company: Luminary Therapeutics

Job title: Founder & CEO

Seminars:

Fireside Chat: Next Generation GDT Cell Therapy for Autoimmune Disorders 2:00 pm

Exploration of preclinical and clinical evidence supporting the use of gamma delta cell therapies in autoimmune conditions. Addressing safety considerations and potential adverse effects associated with gamma delta cell treatments. Evaluation of the challenges and opportunities in translating gamma delta cell therapies from bench to bedside for autoimmune diseases. Consideration of patient selection criteria and…Read more

day: Conference Day Two - Track A - PM

The Role of gdT Cell Therapies in Autoimmunity 12:00 pm

An alternative to CD19 targeting Identifying and removing autoreactive B cells by directlytargeting the B cell activating factor receptors Eliminating the cause of inflammation at the sourceRead more

day: Conference Day Two - Track A - AM